New eye drug could save sight for millions with diabetes
NCT ID NCT06270836
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested an eye injection called tarcocimab in 255 people with diabetic retinopathy, a diabetes complication that can damage vision. Participants received either the drug or a sham (fake) injection. The goal was to see if the drug improves the severity of the disease and prevents sight-threatening complications. The trial is complete, but results are not yet available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
tarcocimab tedromer (injected into the eye)
What this could lead to
If it works, this could offer a new way to slow or stop vision loss from diabetic retinopathy, reducing the need for more invasive treatments.
What could go wrong
This is a completed Phase 3 trial, but results are not yet public. The drug is injected directly into the eye, which carries risks like infection or inflammation. It may not work better than existing treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC RETINOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Asheville Eye Associates
Asheville, North Carolina, 28803, United States
-
Associated Vitreoretinal and Uveitis Consultants
Carmel, Indiana, 46290, United States
-
Austin Research Center for Retina
Austin, Texas, 78705, United States
-
Austin Retina Associates, PLLC (Austin)
Austin, Texas, 78705-1169, United States
-
Austin Retina Associates, PLLC (Round Rock)
Round Rock, Texas, 78681, United States
-
Cascade Medical Research Institute
Springfield, Oregon, 97477, United States
-
Center for Retina and Macular Disease
Winter Haven, Florida, 33880, United States
-
Charles Retina Institute
Germantown, Tennessee, 38138, United States
-
Charleston Neuroscience Institute
Charleston, South Carolina, 29414, United States
-
Cumberland Valley Retina Consultants
Hagerstown, Maryland, 21740, United States
-
Emanuelli Research & Development Center, LLC
Arecibo, 00612, Puerto Rico
-
Envision Ocular, LLC
Bloomfield, New Jersey, 07003, United States
-
Erie Retina Research
Erie, Pennsylvania, 16507, United States
-
Florida Eye Associates
Melbourne, Florida, 32901, United States
-
Global Research Management, Inc. - Lugene Eye Institute
Glendale, California, 91204, United States
-
North Carolina Retina Associates (Cary)
Cary, North Carolina, 27511, United States
-
North Carolina Retina Associates (Wake Forest)
Wake Forest, North Carolina, 27587, United States
-
Pacific Northwest Retina (Bellevue)
Bellevue, Washington, 98004, United States
-
Panhandle Eye Group, LLP. - Southwest Retina Specialists
Amarillo, Texas, 79106, United States
-
Piedmont Eye Center
Lynchburg, Virginia, 24502, United States
-
Retina Associates SW
Tucson, Arizona, 85704, United States
-
Retina Consultants of Nevada
Henderson, Nevada, 89052, United States
-
Retina Consultants of Orange County
Fullerton, California, 92835, United States
-
Retina Consultants of Southern California
Redlands, California, 92374, United States
-
Retina Consultants of Texas (Bellaire)
Bellaire, Texas, 77401, United States
-
Retina Consultants of Texas (Katy)
Katy, Texas, 77494, United States
-
Retina Consultants of Texas (San Antonio)
San Antonio, Texas, 78240, United States
-
Retina Consultants of Texas (Woodlands)
The Woodlands, Texas, 77384, United States
-
Retina Group of Florida
Fort Lauderdale, Florida, 33308, United States
-
Retina Group of New England, PC
Waterford, Connecticut, 06385, United States
-
Retina Research Institute of Texas
Abilene, Texas, 79606, United States
-
Retinal Consultants Medical Group, Inc.
Modesto, California, 95356, United States
-
Retinal Consultants Medical Group, Inc.
Sacramento, California, 95825, United States
-
Southeast Retina Center
Augusta, Georgia, 30909, United States
-
Southeastern Retina Associates PC
Knoxville, Tennessee, 37922, United States
-
Spokane Eye Clinical Research
Spokane, Washington, 99204, United States
-
Springfield Clinic LLP
Springfield, Illinois, 62703, United States
-
Star Vision Research
Burleson, Texas, 76028, United States
-
Texas Retina Associates
Plano, Texas, 75075, United States